Subjects: Government Regulation and Medicare Part D / Recently Added: Within 6 Months - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Government Regulation ✖ Subjects Medicare Part D ✖ Recently Added Within 6 Months ✖

1. Opioid overdoses and the limited treatment of opioid use disorder continue to be concerns for Medicare beneficiaries

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022
Subject(s):: Government Regulation
Medicare Part D
Opiate Overdose
Opioid-Related Disorders
United States

2. Part D plans generally include drugs commonly used by dual eligibles: 2022

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, June 2022
Subject(s):: Dual MEDICAID MEDICARE Eligibility
Government Regulation
Medicare Part D
Prescription Drugs
United States

3. The risk of misuse and diversion of buprenorphine for opioid use disorder appears to be low in Medicare Part D

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, May 2023
Subject(s):: Buprenorphine
Buprenorphine, Naloxone Drug Combination
Government Regulation
Medicare Part D
Opioid-Related Disorders -- drug therapy
United States

4. Part D plans generally include drugs commonly used by dual-eligible enrollees: 2023

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2023
Subject(s):: Dual MEDICAID MEDICARE Eligibility
Formularies as Topic
Government Regulation
Medicare Part D
Prescription Drugs
United States